108 related articles for article (PubMed ID: 20669312)
21. Concurrent administration of coenzyme Q10 and alpha-tocopherol improves learning in aged mice.
McDonald SR; Sohal RS; Forster MJ
Free Radic Biol Med; 2005 Mar; 38(6):729-36. PubMed ID: 15721983
[TBL] [Abstract][Full Text] [Related]
22. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke.
Rundek T; Naini A; Sacco R; Coates K; DiMauro S
Arch Neurol; 2004 Jun; 61(6):889-92. PubMed ID: 15210526
[TBL] [Abstract][Full Text] [Related]
23. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
24. Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
Gathe JC; Wood R; Sanne I; DeJesus E; Schürmann D; Gladysz A; Garris C; Givens N; Elston R; Yeo J
Clin Ther; 2006 May; 28(5):745-54. PubMed ID: 16861096
[TBL] [Abstract][Full Text] [Related]
25. Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10.
Biglan KM; Dorsey ER; Evans RV; Ross CA; Hersch S; Shoulson I; Matson W; Kieburtz K;
J Huntingtons Dis; 2012; 1(1):65-9. PubMed ID: 25063191
[TBL] [Abstract][Full Text] [Related]
26. Effect of coenzyme Q10 on stress-induced cardiac dysfunction in paediatric patients with mitral valve prolapse: a study by stress echocardiography.
Oda T
Drugs Exp Clin Res; 1985; 11(8):557-76. PubMed ID: 3836874
[TBL] [Abstract][Full Text] [Related]
27. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
28. Coenzyme Q10 absorption and tolerance in children with Down syndrome: a dose-ranging trial.
Miles MV; Patterson BJ; Schapiro MB; Hickey FJ; Chalfonte-Evans M; Horn PS; Hotze SL
Pediatr Neurol; 2006 Jul; 35(1):30-7. PubMed ID: 16814082
[TBL] [Abstract][Full Text] [Related]
29. Coenzyme Q10 distribution in blood is altered in patients with fibromyalgia.
Cordero MD; Moreno-Fernández AM; deMiguel M; Bonal P; Campa F; Jiménez-Jiménez LM; Ruiz-Losada A; Sánchez-Domínguez B; Sánchez Alcázar JA; Salviati L; Navas P
Clin Biochem; 2009 May; 42(7-8):732-5. PubMed ID: 19133251
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study.
Kremer JM; Habros JS; Kolba KS; Kaine JL; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisemandle W; Mekki QA;
Arthritis Rheum; 2003 Oct; 48(10):2763-8. PubMed ID: 14558080
[TBL] [Abstract][Full Text] [Related]
31. Sodium phenylbutyrate in Huntington's disease: a dose-finding study.
Hogarth P; Lovrecic L; Krainc D
Mov Disord; 2007 Oct; 22(13):1962-4. PubMed ID: 17702032
[TBL] [Abstract][Full Text] [Related]
32. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
33. Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.
Hickey MA; Zhu C; Medvedeva V; Franich NR; Levine MS; Chesselet MF
Mol Cell Neurosci; 2012 Feb; 49(2):149-57. PubMed ID: 22044764
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
Wagg A; Wyndaele JJ; Sieber P
Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of levetiracetam in Huntington disease.
de Tommaso M; Di Fruscolo O; Sciruicchio V; Specchio N; Cormio C; De Caro MF; Livrea P
Clin Neuropharmacol; 2005; 28(6):280-4. PubMed ID: 16340384
[TBL] [Abstract][Full Text] [Related]
36. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
[TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations.
Villalba JM; Parrado C; Santos-Gonzalez M; Alcain FJ
Expert Opin Investig Drugs; 2010 Apr; 19(4):535-54. PubMed ID: 20367194
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
McGarry A; McDermott M; Kieburtz K; de Blieck EA; Beal F; Marder K; Ross C; Shoulson I; Gilbert P; Mallonee WM; Guttman M; Wojcieszek J; Kumar R; LeDoux MS; Jenkins M; Rosas HD; Nance M; Biglan K; Como P; Dubinsky RM; Shannon KM; O'Suilleabhain P; Chou K; Walker F; Martin W; Wheelock VL; McCusker E; Jankovic J; Singer C; Sanchez-Ramos J; Scott B; Suchowersky O; Factor SA; Higgins DS; Molho E; Revilla F; Caviness JN; Friedman JH; Perlmutter JS; Feigin A; Anderson K; Rodriguez R; McFarland NR; Margolis RL; Farbman ES; Raymond LA; Suski V; Kostyk S; Colcher A; Seeberger L; Epping E; Esmail S; Diaz N; Fung WL; Diamond A; Frank S; Hanna P; Hermanowicz N; Dure LS; Cudkowicz M;
Neurology; 2017 Jan; 88(2):152-159. PubMed ID: 27913695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
